🔎 Trials Near Me

Beranda › Penyakit Crohn › Arizona

Uji klinis Penyakit Crohn di Arizona

17 studi untuk Penyakit Crohn mencari peserta di lokasi di Arizona.

Kota di Arizona

Teks studi resmi (Bahasa Inggris)

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

  • GI Alliance - Sun City ( Site 5118), Sun City
  • University of Arizona Clinical and Translational Sciences Research Center ( Site 5111), Tucson
Menerima pesertaFase 3
Usia 16 hingga 80 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06430801

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

  • Elite Clinical Studies /ID# 280477, Phoenix
  • Gi Alliance - Arizona Digestive Health - Sun City /ID# 284084, Sun City
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07697456

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

  • AZ Gastro Care, Chandler
  • Spectrum Research Institute LLC, Gilbert
  • GI Alliance- Sun City, Sun City
Menerima pesertaFase 4
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT06581328

A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

  • AZ Gastro Care, Chandler
  • Research Solutions of Arizona, Litchfield Park
  • Mayo Clinic, Scottsdale
Menerima pesertaFase 2/3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07196722

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

  • Onyx Clinical Research - Site Number:8400021, Peoria
  • One of a Kind Clinical Research Center AZ, LLC-Site Number: 8400061, Scottsdale
  • Scottsdale Clinical Trials-Site Number: 8400145, Scottsdale
  • dan 1 lainnya
Menerima pesertaFase 3
Usia 16 hingga 80 · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT07184931

A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease

  • Phoenix Children's Hospital /ID# 255766, Phoenix
Menerima pesertaFase 3
Usia 2 hingga 17 · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT05995353

A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

  • GI Alliance Sun City, Sun City
Menerima pesertaFase 4
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT06045754

Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

  • Mayo Clinic Arizona, Scottsdale
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 7 Agu 2026 · NCT05230173

A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease

  • Phoenix Children's Hospital, Phoenix
Menerima pesertaFase 3
Usia 2 hingga 17 · Semua jenis kelamin · Diperbarui 3 Agu 2026 · NCT06100289

A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)

  • Phoenix Childrens Hospital, Phoenix
Menerima pesertaFase 3
Usia 2 hingga 17 · Semua jenis kelamin · Diperbarui 22 Jun 2026 · NCT06405087

Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease

  • Phoenix Children's Hospital, Phoenix
Menerima pesertaFase 4
Usia 6 hingga 17 · Semua jenis kelamin · Diperbarui 27 Mei 2026 · NCT05781152

A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)

  • Phoenix Childrens Hospital - Thomas Rd - PIN, Phoenix
Menerima pesertaFase 3
Usia 2 ke atas · Semua jenis kelamin · Diperbarui 7 Mei 2026 · NCT05442567

A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)

  • Phoenix Childrens Hospital, Phoenix
Menerima pesertaFase 3
Usia 2 hingga 17 · Semua jenis kelamin · Diperbarui 5 Mei 2026 · NCT04779320

Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease

  • Scottsdale Gastroenterology Specialists, Scottsdale
  • GI Alliance -Gurnee, Sun City
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 27 Apr 2026 · NCT06456593

A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease

  • Investigational Site Number: 8400024, Tucson
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 27 Mar 2026 · NCT06958536

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

  • Mirador Therapeutics Selected Site, Scottsdale
  • Mirador Therapeutics Selected Site, Sun City
Menerima pesertaFase 2
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 12 Mar 2026 · NCT07113522

Treatment of Moderate to Severe Refractory Crohn's Disease

  • Mayo Clinic Arizona, Scottsdale
Menerima pesertaFase 1/2
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 10 Des 2025 · NCT06721962

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.